These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6392935)

  • 1. [Clinical, immunologic and electrophysiologic correlations in evaluating multiple sclerosis in relation to its development].
    Cazzullo CL; Montanini R; Ghezzi A; Zaffaroni M; Giussani D; Loner R; Caputo D; Marforio S; Zibetti A
    Minerva Med; 1984 Nov; 75(43):2585-9. PubMed ID: 6392935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The diagnostic value of nuclear magnetic resonance tomography, multimodal evoked potentials and cerebrospinal fluid examination in multiple sclerosis].
    Staffen W; Trinka E; Ladurner G
    Nervenarzt; 1993 Apr; 64(4):226-32. PubMed ID: 8506010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of serial lymphocyte subsets in multiple sclerosis: their possible role in the evaluation of disease progression.
    Cazzullo CL; Zaffaroni M; Caputo D; Ghezzi A
    Riv Neurol; 1987; 57(1):24-6. PubMed ID: 2957783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Visual and somatosensory evoked potentials and immunologic indices in multiple sclerosis].
    Mukhtarova AA; Sokolova LI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(2):193-7. PubMed ID: 6608844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of three FcR-positive T cell subsets (T gamma, T mu and T gamma mu) in the cerebrospinal fluid of multiple sclerosis patients.
    Merrill JE; Biberfeld G; Landin S; Sidén A; Norrby E
    Clin Exp Immunol; 1980 Nov; 42(2):345-54. PubMed ID: 6970641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum vitamin B12, folate, and homocysteine levels and their association with clinical and electrophysiological parameters in multiple sclerosis.
    Kocer B; Engur S; Ak F; Yilmaz M
    J Clin Neurosci; 2009 Mar; 16(3):399-403. PubMed ID: 19153046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure to develop multiple sclerosis in patients with neurologic symptoms without objective evidence.
    Boster A; Caon C; Perumal J; Hreha S; Zabad R; Zak I; Tselis A; Lisak R; Khan O
    Mult Scler; 2008 Jul; 14(6):804-8. PubMed ID: 18573830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between clinical conversion to multiple sclerosis in radiologically isolated syndrome and magnetic resonance imaging, cerebrospinal fluid, and visual evoked potential: follow-up of 70 patients.
    Lebrun C; Bensa C; Debouverie M; Wiertlevski S; Brassat D; de Seze J; Rumbach L; Pelletier J; Labauge P; Brochet B; Tourbah A; Clavelou P;
    Arch Neurol; 2009 Jul; 66(7):841-6. PubMed ID: 19597085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive role of evoked potential examinations in patients with clinically isolated optic neuritis in light of the revised McDonald criteria.
    Simó M; Barsi P; Arányi Z
    Mult Scler; 2008 May; 14(4):472-8. PubMed ID: 18208873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neurophysiological assessment in patients with clinically defined multiple sclerosis with special reference to P300 wave study].
    Casanova-González MF; Cabrera-Gómez JA; Aquino-Cías J; Aneiros-Rivas R; Fernández-Bermúdez R
    Rev Neurol; 1999 Dec 16-31; 29(12):1134-7. PubMed ID: 10652735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influx of nonactivated T lymphocytes into the cerebrospinal fluid during relapse of multiple sclerosis.
    Oksaranta O; Tarvonen S; Ilonen J; Poikonen K; Reunanen M; Panelius M; Salonen R
    Ann Neurol; 1995 Sep; 38(3):465-8. PubMed ID: 7668836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between disability and transcranial magnetic stimulation abnormalities in patients with multiple sclerosis.
    Kale N; Agaoglu J; Onder G; Tanik O
    J Clin Neurosci; 2009 Nov; 16(11):1439-42. PubMed ID: 19695880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics of multiple sclerosis in Lebanon.
    Yamout B; Barada W; Tohme RA; Mehio-Sibai A; Khalifeh R; El-Hajj T
    J Neurol Sci; 2008 Jul; 270(1-2):88-93. PubMed ID: 18367208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlations between monthly enhanced MRI lesion rate and changes in T2 lesion volume in multiple sclerosis.
    Molyneux PD; Filippi M; Barkhof F; Gasperini C; Yousry TA; Truyen L; Lai HM; Rocca MA; Moseley IF; Miller DH
    Ann Neurol; 1998 Mar; 43(3):332-9. PubMed ID: 9506550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multimodal evoked potentials in multiple sclerosis: basal and follow-up data.
    Gambi D; Rossini PM; Marchionno L; Iarlori T; Finarelli A; Pirchio M
    Adv Neurol; 1982; 32():551-7. PubMed ID: 7054984
    [No Abstract]   [Full Text] [Related]  

  • 16. [Acute myelopathies in young patients and multiple sclerosis. prospective study of 20 cases].
    Dalecky A; Pelletier J; Chérif AA; Lévrier O; Khalil R
    Rev Neurol (Paris); 1997 Oct; 153(10):569-78. PubMed ID: 9684021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilization of the multiple sclerosis functional composite in follow-up: relationship to disease phenotype, disability and treatment strategies.
    Ozakbas S; Ormeci B; Idiman E
    J Neurol Sci; 2005 May; 232(1-2):65-9. PubMed ID: 15850584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multimodal evoked potentials measure and predict disability progression in early relapsing-remitting multiple sclerosis.
    Jung P; Beyerle A; Ziemann U
    Mult Scler; 2008 May; 14(4):553-6. PubMed ID: 18562509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical correlations and evoked potentials in 29 cases of definitive multiple sclerosis].
    Ferrer S; Jiménez P; Mellado L; Thieck E
    Rev Med Chil; 1993 Oct; 121(10):1154-60. PubMed ID: 8191120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serial blood T cell repertoire alterations in multiple sclerosis patients; correlation with clinical and MRI parameters.
    Laplaud DA; Berthelot L; Miqueu P; Bourcier K; Moynard J; Oudinet Y; Guillet M; Ruiz C; Oden N; Brouard S; Guttmann CR; Weiner HL; Khoury SJ; Soulillou JP
    J Neuroimmunol; 2006 Aug; 177(1-2):151-60. PubMed ID: 16806500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.